GRI BIO, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
GRI BIO, INC. (GRI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $3.27 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-01-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-01-30
- GRI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $3.27M, a 51.04% increase from fiscal 2024.
- GRI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.16M, a 80.38% decline from fiscal 2023.
- GRI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $11.03M.
- GRI BIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$2.18M, a 176.26% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $3.27M 10-K · filed 2026-01-30 |
| 2024-12-31 | $2.16M 10-K · filed 2025-03-14 |
| 2023-12-31 | $11.03M 10-K · filed 2024-03-28 |
| 2022-12-31 | -$2.18M 10-K · filed 2023-02-24 |
| 2021-12-31 | $2.86M 10-K · filed 2022-02-14 |